文献速递遗传性与小管间质肾病慢性肾脏病

通过外显子组测序系统筛查ADTKD-MUC1 27dupC致病变异

Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease- MUC1 27dupC Pathogenic Variant through Exome Sequencing.
PubMed 文献 · J Am Soc Nephrol · 2024-09-26

本研究开发了SharkVNTyper生物信息学流程,可从外显子组测序数据中系统检测MUC1 27dupC致病变异。在概念验证队列中敏感度97%、特异度100%,回顾性队列额外发现23例阳性(18例经PCR确认),前瞻性队列825例中检出13例阳性(12例确认)。全部4653例中分子确诊ADTKD-MUC1者占1.4%,中位肾衰竭年龄50岁。

要点

  • SharkVNTyper可系统筛查外显子组数据中的MUC1 27dupC变异,敏感度97%、特异度100%。
  • 回顾性分析3512例未知病因肾病患者,额外检出23例阳性,其中18例经PCR确认。
  • 4653例中分子确诊ADTKD-MUC1占1.4%,中位肾衰竭年龄50岁。

核心结论

  • SharkVNTyper能够分析MUC1 VNTR等高重复区域,实现从外显子组数据中系统筛查ADTKD-MUC1并促进27dupC变异的鉴定。

研究设计与样本

  • 概念验证队列纳入33例已知MUC1致病变异者(Snapshot PCR识别)和54例MUC1阴性对照。
  • 回顾性分析2019年1月至2023年10月3512例未知病因肾病的成人外显子组测序数据。
  • 前瞻性验证2023年11月起入组的825例额外参与者。

主要发现

  • 概念验证队列中SharkVNTyper准确识别33例中的32例MUC1变异,并在全部54例阴性对照中排除其存在(敏感度97%,特异度100%)。
  • Shark与VNTyper整合将每样本运行时间从6–12小时显著缩短至5–10分钟。
  • 回顾性队列中SharkVNTyper额外识别23例临床未怀疑且初始外显子分析遗漏的阳性参与者,其中18例经低通量Snapshot PCR确认携带MUC1 27dupC突变。
  • 前瞻性825例CKD参与者中系统筛查发现13例阳性,其中12例经PCR确认。
  • 4653例中分子确诊ADTKD-MUC1者63例(1.4%),其中24例有全面诊断和疾病描述:中位肾衰竭年龄50岁,38%有双侧多发性肾囊肿,8%有早发性痛风,58%有动脉性高血压。

临床怎么用

  • 对于病因不明的肾病尤其是CKD患者,可应用SharkVNTyper流程从外显子组数据中系统筛查MUC1 27dupC变异。
  • 该流程运行时间短(每样本5–10分钟),支持回顾性和前瞻性分析,有助于发现临床未怀疑的ADTKD-MUC1病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: MUC1 is associated with autosomal dominant tubulointerstitial kidney disease, a genetic disorder progressing to kidney failure. Variations in this gene are not easily diagnosed by conventional methods due to the MUC1 architecture, which contains a variable number of tandem repeats. Using dedicated bioinformatics tools, we systematically detected the presence of 27dupC most common MUC1 pathogenic variant from exome sequencing data. BACKGROUND: The MUC1 gene is associated with autosomal dominant tubulointerstitial kidney disease (ADTKD), leading to CKD. Current methods of sequencing, such as exome sequencing, rarely detect MUC1 pathogenic variants because of the variable number of tandem repeats (VNTR) in MUC1 exon2. We demonstrated that combining fast read filtering with a sensitive VNTR genotyping strategy enables systematic screening of 27dupC pathogenic MUC1 variant from exome data. METHODS: We initially validated our bioinformatics pipeline in a proof-of-concept cohort incorporating exome data from 33 participants with a known MUC1 pathogenic variant identified by Snapshot PCR and confirmed by 54 MUC1-negative individuals for negative control. We then retrospectively analyzed exome sequencing data from January 2019 to October 2023 from 3512 adult participants with nephropathy of unknown origin. Finally, we prospectively validated our pipeline in 825 additional participants enrolled from November 2023. RESULTS: SharkVNTyper accurately identified MUC1 variants in 32 of 33 participants and excluded its presence in all the 54 negative controls in the proof-of-concept cohort (sensitivity of 97%, specificity of 100%). Integration of the Shark tool with VNTyper significantly reduced running time from 6–12 hours to 5–10 minutes per sample, allowing both retrospective and prospective analyses. In the retrospective cohort, SharkVNTyper identified 23 additional positive participants who were not suspected clinically and had been missed in the initial exome analysis; 18 of these participants were confirmed as carrying the MUC1 27dupC mutation by low-throughput Snapshot PCR. In the prospective cohort of 825 participants with CKD, systematic screening discovered 13 positive participants, with 12 confirmed by PCR. Overall, of 63 participants (1.4% of 4653) with molecularly confirmed ADTKD-MUC1, comprehensive diagnoses and descriptions of the disease were available for 24 participants. The median age of kidney failure was 50 years, 38% exhibited bilateral multiple kidney cysts, 8% had early-onset gout, and 58% had arterial hypertension. CONCLUSIONS: SharkVNTyper enabled the analysis of highly repeated regions, such as the MUC1 VNTR, and facilitated the systematic screening of ADTKD-MUC1 from exome data, fostering 27dupC variation identification. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_11_15_KTS_November2024.mp3

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bensouna I, Robert T, Vanhoye X, et al. Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease- MUC1 27dupC Pathogenic Variant through Exome Sequencing. J Am Soc Nephrol. 2024. PMID: 39325540. doi:10.1681/ASN.0000000503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。